Sarepta Therapeutics Inc
XMUN:AB3A
Sarepta Therapeutics Inc
XMUN:AB3A
Price:
14.54
EUR
4.6%
Market Closed
Market Cap:
€902.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Sarepta Therapeutics Inc
XMUN:AB3A
|
US |
|
F
|
Franklin Resources Inc
DUS:FRK
|
US |
|
I
|
Isetan Mitsukoshi Holdings Ltd
DUS:4HP
|
JP |
|
Koninklijke Philips NV
AEX:PHIA
|
NL |
|
F
|
Franklin Resources Inc
BMV:BEN
|
US |
|
B
|
Bank of New York Mellon Corp
F:BN9
|
US |
|
P
|
Parker-Hannifin Corp
F:PAR
|
US |
|
Telekom Austria AG
LSE:0NKL
|
AT |
|
Koninklijke Ahold Delhaize NV
AEX:AD
|
NL |
Multiples-Based Value
The Multiples-Based Value for 
Sarepta Therapeutics Inc (AB3A) under the Base Case is hidden
EUR.
Compared with the current market price of 14.54 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
AB3A Multiples-Based Value
LOCKED
